80 related articles for article (PubMed ID: 22264762)
1. Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression.
Hennrich U; Seyler L; Schäfer M; Bauder-Wüst U; Eisenhut M; Semmler W; Bäuerle T
Bioorg Med Chem; 2012 Feb; 20(4):1502-10. PubMed ID: 22264762
[TBL] [Abstract][Full Text] [Related]
2. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
3. [(68)Ga]Ga-DO(2)A-(OBu-l-tyr)(2): synthesis, (68)Ga-radiolabeling and in vitro studies of a novel (68)Ga-DO(2)A-tyrosine conjugate as potential tumor tracer for PET.
Burchardt C; Riss PJ; Zoller F; Maschauer S; Prante O; Kuwert T; Roesch F
Bioorg Med Chem Lett; 2009 Jul; 19(13):3498-501. PubMed ID: 19477125
[TBL] [Abstract][Full Text] [Related]
4. A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging.
Sano K; Masuda R; Hisada H; Oishi S; Shimokawa K; Ono M; Fujii N; Saji H; Mukai T
Bioorg Med Chem Lett; 2014 Mar; 24(5):1386-8. PubMed ID: 24491461
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a CXCR4-specific (68)Ga-labelled TN14003 derivative for cancer PET imaging.
George GP; Stevens E; Åberg O; Nguyen QD; Pisaneschi F; Spivey AC; Aboagye EO
Bioorg Med Chem; 2014 Jan; 22(2):796-803. PubMed ID: 24365390
[TBL] [Abstract][Full Text] [Related]
6. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.
Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ
J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709
[TBL] [Abstract][Full Text] [Related]
7. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
[TBL] [Abstract][Full Text] [Related]
8. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
9. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.
Lechertier T; Berard M; Vassy R; Herve MA; Crepin M
Anticancer Res; 2004; 24(6):4011-7. PubMed ID: 15739262
[TBL] [Abstract][Full Text] [Related]
10. PET of tumor CXCR4 expression with 4-18F-T140.
Jacobson O; Weiss ID; Kiesewetter DO; Farber JM; Chen X
J Nucl Med; 2010 Nov; 51(11):1796-804. PubMed ID: 20956475
[TBL] [Abstract][Full Text] [Related]
11. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
[TBL] [Abstract][Full Text] [Related]
12. Improvement of CXCR4 tracer specificity for PET imaging.
Jacobson O; Weiss ID; Szajek LP; Niu G; Ma Y; Kiesewetter DO; Peled A; Eden HS; Farber JM; Chen X
J Control Release; 2012 Jan; 157(2):216-23. PubMed ID: 21964282
[TBL] [Abstract][Full Text] [Related]
13. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
14. Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.
Kuil J; Steunenberg P; Chin PT; Oldenburg J; Jalink K; Velders AH; van Leeuwen FW
Chembiochem; 2011 Aug; 12(12):1897-903. PubMed ID: 21739561
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
[TBL] [Abstract][Full Text] [Related]
18. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
19. Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4.
Masuda R; Oishi S; Ohno H; Kimura H; Saji H; Fujii N
Bioorg Med Chem; 2011 May; 19(10):3216-20. PubMed ID: 21524584
[TBL] [Abstract][Full Text] [Related]
20. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]